HeRO News2020-02-25T10:06:53-05:00

Neonatal Update 2020

We are proud to sponsor Imperial College London’s Neonatal Update 2020. The conference has been an annual event for 40 years. This year, it will be held virtually. Professor Neena Modi and Dr. Vimal Vasu have put together a great 5-day programme. Please register now and join in.

October 27th, 2020|

HeRO Monitoring – Does it Lead to Unnecessary Testing and Treatment?

Days Alive without unnecessary testing

June 23, 2020 – MPSC announces the publication of another article about HeRO. In this peer reviewed article published in Neonatology Today, King discusses the use of predictive monitoring tools such as HeRO. Some fear that the use of tools such as HeRO may lead to higher rates of testing and antibiotic usage. In the article, the data regarding these concerns from multiple prior analyses are assessed in the context of improved outcomes.

June 23rd, 2020|

New HeRO Publication in European Respiratory Journal

June 22, 2020 – MPSC is proud to announce that the European Respiratory Journal has published “Predicting Extubation Outcomes Using Heart Rate Characteristics Index in Preterm Infants: A Cohort Study.” In this paper, Chakraborty et. al. expand upon their earlier publication on the use of HeRO to assess extubation outcomes. With this publication, the authors also announce a free online tool that applies the models presented in the publication for the use by neonatologists everywhere.

June 22nd, 2020|

MPSC releases Episode 2 of the HeRO Whiteboard – Cytokines and HRV

June 22 – Today, MPSC announces the release of the next episode of our video series, The HeRO Whiteboard. In today’s episode, we explore the physiological response to a developing infection and how the release of cytokines leads to changes in heart rate variability. HeRO assesses heart rate variability in its algorithm for determining the HeRO Score.

June 22nd, 2020|

MPSC releases the Episode 1 of The HeRO Whitebaord

June 11, 2020 – Today, MPSC is proud to announce the release of the first episode of The HeRO Whiteboard. In this episode, we provide an introduction to HeRO as well as the subjects to be covered in the successive episodes.

June 12th, 2020|

MPSC announces The HeRO Whiteboard

June 4, 2020 – MPSC is proud to announce The HeRO Whiteboard. Many of our customers have asked for a video message to learn more about HeRO. In this series, we present the HeRO product and provide an educational session in this short video format.

June 12th, 2020|

HeRO looks to create new partnerships following ArabHealth 2020.

ArabHealth 2020 boothWe are excited from a tremendous show at #ArabHealth2020 in Dubai. We want to thank @VEDPVirginia for the support and the opportunity to present as a part of the Virginia stand.

ArabHealth is always a great conference to meet with customers, friends, and partners in the Gulf region. We look forward to lots of opportunities and new business.

February 18th, 2020|

MPSC moves to new headquarters

Medical Predictive Science Corporation, MPSC, has completed the move of its headquarters to a new location. “Our relocation will continue to allow for further growth of the company and the additional headcount needed to support it,” said Will King, CEO.

Please take note of our new address, effective immediately:
Medical Predictive Science Corp.
1233 Cedars Ct, Ste 201
Charlottesville, VA 22901

December 9th, 2019|

HeRO announces Tomorrow Medical as new distributor.

Charlottesville, VA– June 7th, 2019 MPSC announced today that it has signed an exclusive relationship with Tomorrow Medical to represent the HeRO products in the Netherlands, Germany, and Belgium.

Tomorrow Medical

“Tomorrow Medical is delighted to offer HeRO as a part of its mission to extend and improve life and health by early treatment of health risks,” says its founder, Rob de Vroet. “We strive to provide the highest quality service to our customers and patients.”

Now available in 26 countries, HeRO is becoming the standard of care in providing actionable information to improve the care for neonatal intensive care patients.

In the NICU, sepsis is the leading cause of death after the first three days of life.   It is goal of MPSC to aid doctors to identify and treat earlier, when those treatments are most effective.  MPSC’s HeRO product applies the concept of “Big Data” to generate meaningful clinical decision support solutions.

Medical Predictive Science Corporation is engaged in the development of computational diagnostic and bio-informatic technologies for the healthcare industry.  MPSC is committed to saving lives and reducing healthcare expenditures through the development of effective clinical diagnostic and decision support tools.  These products use computational diagnostic methods to make the early d